- Home
- GGT vs ENTA Comparison
GGT vs ENTA Comparison
Compare GGT & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGT
- ENTA
- Stock Information
- Founded
- GGT 1994
- ENTA 1995
- Country
- GGT United States
- ENTA United States
- Employees
- GGT N/A
- ENTA N/A
- Industry
- GGT Trusts Except Educational Religious and Charitable
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- GGT Finance
- ENTA Health Care
- Exchange
- GGT Nasdaq
- ENTA Nasdaq
- Market Cap
- GGT 136.5M
- ENTA 127.8M
- IPO Year
- GGT N/A
- ENTA 2013
- Fundamental
- Price
- GGT $4.86
- ENTA $6.28
- Analyst Decision
- GGT
- ENTA Buy
- Analyst Count
- GGT 0
- ENTA 4
- Target Price
- GGT N/A
- ENTA $19.50
- AVG Volume (30 Days)
- GGT 59.7K
- ENTA 537.1K
- Earning Date
- GGT 01-01-0001
- ENTA 02-05-2025
- Dividend Yield
- GGT 15.56%
- ENTA N/A
- EPS Growth
- GGT N/A
- ENTA N/A
- EPS
- GGT 0.83
- ENTA N/A
- Revenue
- GGT N/A
- ENTA $67,635,000.00
- Revenue This Year
- GGT N/A
- ENTA $11.80
- Revenue Next Year
- GGT N/A
- ENTA $3.99
- P/E Ratio
- GGT $6.90
- ENTA N/A
- Revenue Growth
- GGT N/A
- ENTA N/A
- 52 Week Low
- GGT $4.32
- ENTA $5.70
- 52 Week High
- GGT $7.00
- ENTA $17.80
- Technical
- Relative Strength Index (RSI)
- GGT 49.92
- ENTA 31.04
- Support Level
- GGT $4.61
- ENTA $5.70
- Resistance Level
- GGT $5.12
- ENTA $6.56
- Average True Range (ATR)
- GGT 0.08
- ENTA 0.74
- MACD
- GGT -0.04
- ENTA -0.11
- Stochastic Oscillator
- GGT 48.08
- ENTA 14.91
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.